Pharmacological Management of Chronic Functional Constipation

Article information

J Korean Med Assoc. 2005;48(3):287-292
Publication date (electronic) : 2005 March 31
doi : https://doi.org/10.5124/jkma.2005.48.3.287
Department of Gastroenterology, Ajou University School of Medicine & Hospital, Korea. kjleemd@hotmail.com

Abstract

Functional constipation is regarded as a long-standing symptomatic manifestation of abnormal defecation expressed either by a reduced frequency of bowel movements and/or by an altered act of evacuation. Patients with constipation can be treated with laxatives, diets, and regular habits. A thorough evaluation of functional constipation is considered when conservative treatment with dietary advice and use of laxatives fail. Patients with a normal colonic transit and normal anorectal function may only need reassurance, education and dietary advice with fiber supplementation. When such treatment modalities fail to relieve constipation, laxatives including bulkforming and osmotic agents may be used. Although most laxatives, if used intermittently, are relatively safe, possible side effects, patient compliance and their action mechanisms should be considered when choosing a laxative. A subgroup of patients with a slow colonic transit may not be managed by conventional laxatives, and may need enteroprokinetics or stimulant laxatives. This article reviews the assessment and pharmacological treatment of functional constipation.

References

3. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lisser SA. Functional bowel disorders and functional abdominal pain. Gut 1999. 45Suppl 2. II43–II47.
4. Rao SSC. Constipation: evaluation and treatment. Gastroenterol Clin North Am 2003. 32659–683.

Article information Continued

Table 1

Table 1

Table 2

Table 2

Table 3

Table 3